Substance use and women's health

Journal of Addictive Diseases

Volumn 29, Issue 2, 2010, Pages 139-163

  Kay, Abigail ^a   Taylor, Trusandra E ^b   Barthwell, Andrea G ^c   Wichelecki, Jana ^d   Leopold, Vera ^d  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b JEVS Human Services   (United States)

^c EMGlobal LLC   (United States)

^d Human Resources Development Institute Inc   (United States)

Author keywords

Alcohol abuse; Breast cancer; Cancer; Cardiovascular disease; Cocaine; Diabetes; Minority substance abuse; Opioids; Osteoporosis; Stimulants; Stroke; Women's alcohol abuse; Women's drug abuse; Women's health; Women's substance abuse

Indexed keywords

ANALGESIC AGENT; CENTRAL STIMULANT AGENT; COCAINE; DIAMORPHINE; METHADONE; OPIATE; OXYCODONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY DISORDER; BONE INJURY; BREAST CANCER; CANCER RISK; CANNABIS SMOKING; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; EDUCATION; EMPLOYMENT; ENDOCRINE DISEASE; ENDOMETRIUM CANCER; ESTROGEN DEFICIENCY; GENITAL TRACT CANCER; GOVERNMENT; HEALTH CARE COST; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LIVER DISEASE; LUNG CANCER; LUNG VENTILATION; MEDICAL RESEARCH; MENOPAUSE; MENSTRUAL CYCLE; MOOD DISORDER; MORTALITY; NATIONAL HEALTH ORGANIZATION; NEOPLASM; NEUROLOGIC DISEASE; OBESITY; OPIATE ADDICTION; OSTEOPOROSIS; OVARY CANCER; PAIN; PARTNER VIOLENCE; PATIENT ASSESSMENT; PRESCRIPTION; QT PROLONGATION; QUESTIONNAIRE; REVIEW; SCREENING; SEX DIFFERENCE; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TORSADE DES POINTES; URINARY TRACT CANCER; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

ALCOHOL DRINKING; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; HUMANS; MALE; POVERTY; RISK FACTORS; RISK-TAKING; SEX FACTORS; SMOKING; SUBSTANCE-RELATED DISORDERS; TOBACCO USE DISORDER; WOMEN'S HEALTH;

EID: 77951446326     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550881003684640     Document Type: Review

References (221)

1. U.S. Dept. of Health andHuman Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. TREATMENT EPISODE DATA SET (TEDS), 1992-2006 (Concatenated) [Computer file]. Prepared by Synectics, Incorporated. ICPSR02184-v8. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [producer and distributor], 2006-12-108
2. Executive Office of the President. Office of National Drug Control Policy. 2004, December. The economic costs of drug abuse in the United States 1992- 2002 Available from: http://www.whitehousedrugpolicy. gov/publications/ economic costs/economic costs.pdf. Accessed March 12, 2009 2002. Available from: http://www.whitehousedrugpolicy. gov/publications/economic costs/economic costs.pdf. Accessed March 12, 2009.
3. Blehar MC. Women's mental health research: the emergence of a biomedical field.AnnualReviewofClinical Psychology 2006; 2:135-160
4. Norsigian J. Boston women's health book collective: our bodies, ourselves. Boston, MA: New England Free Press, 1973.
5. The Nation's Medical Research Agency. National Institutes of Health Web site. Available from: http://www. nih.gov/about/NIHoverview.html. Accessed March 12, 2009.
6. National Institutes of Health. NIH guidelines on the inclusion of women and minorities as subjects in clinical research. Bethesda, MD: NIH Guide, 1994: 23.
7. Frank DA, Jacobs RR, Beeghly M, Augustyn M, Bellinger D, Cabral H, Heeren T. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight pediatrics. Pediatrics 2002; 110:1143-1152
8. Lumeng JC, Cabral HJ, Gannon K, Heeren T, Frank DA. Pre-natal exposures to cocaine and alcohol and physical growth patterns to age 8 years. Neurotoxicol Teratol 2007; 29:446-457
9. Morrow CE, Bandstra ES, Anthony JC, Ofir AY, Xue L, Reyes MB. Influence of prenatal cocaine exposure on early language development: longitudinal findings from four months to three years of age. J Dev Behav Pediatr 2003; 24:39-50.
10. Bandstra ES, Morrow CE, Vogel AL, Fifer RC, Ofir AY, Dausa AT, Xue L, Anthony JC. Longitudinal influence of prenatal cocaine exposure on child language functioning. Neurotoxicol Teratol 2002; 24:297-308.
11. Chou SP, Dawson DA. A study of the gender differences in morbidity among individuals diagnosed with alcohol abuse and/or dependence. J Subst Abuse 1994; 6:381-392
12. Gomberg ES. Women and alcohol: use and abuse. J Nerv Ment Dis1993; 181:211-219
13. Wong CJ, Badger GJ, Sigmon SC, Higgins ST. Examining possible gender differences among cocainedependent outpatients. Exp Clin Psychopharmacol 2002; 10:316-323
14. Hser YI, Huang D, Teruya C, Anglin DM. Gender comparisons of drug abuse treatment outcomes and predictors. Drug Alcohol Depend 2003; 72:255-264
15. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the NationalComorbidity Survey.Arch Gen Psychiatry 1997; 54:313-321
16. Grella CE, Karno MP,Warda US, Niv N, Moore AA. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav 2009; 34(6- 7):498-504.
17. Orford J, Keddie A. Gender differences in the functions and effects of moderate and excessive drinking. Br J Clin Psychol 1985; 24:265-279
18. Randall CL, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME. Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol 1999; 60:252-260
19. Diehl A, Croissant B, Batra A, Mundle G, Nakovics H, Mann K. Alcoholism in women: Is it different in onset and outcome compared to men? Eur Arch Psychiatry Clin Neurosci 2007; 257:344-351
20. Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004; 74:265-272
21. Johnson PB, Richter L, Kleber HD, McLellan AT, Carise D. Telescoping of drinking-related behaviors: gender, racial. Subst Use Misuse 2005; 40:1139-1151
22. Mann K, Ackermann K, Croissant B, Mundle G, Nakovics H, Diehl A. Neuroimaging of gender differences in alcohol dependence: are women more vulnerable? Alcohol Clin Exp Res 2005; 29:896-901.
23. Halliday A, Bush B, Cleary P, Aronson M, Delbanco T. Alcohol abuse in women seeking gynecologic care. Obstet Gynecol 1986; 68:322.
24. Ashley MJ, Olin JS, le Riche WH, Kornaczewski A, Schmidt W, Rankin JG. Morbidity in alcoholics: Evidence for accelerated development of physical disease in women. Arch Intern Med 1977; 137:883-887
25. Hill SY. Biological consequences of alcoholism and alcohol-related problems among women. In: Special Populations Issues. National Institute on Alcohol Abuse and Alcoholism. Alcohol and Health Monograph No. 4. DHHS Pub. No. (ADM)82-1193.Washington, DC: Superintendent of Documents, U.S. Government PrintingOffice, 1982: 43-73.
26. Coombs RH. Addiction counseling review: preparing for comprehensive, certification and licensing examinations. New York: Routledge, 2005.
27. Jones BM, Jones MK. Women and alcohol: intoxication, metabolism, and the menstrual cycle. In: Greenblatt M, Schuckit MA, eds. Alcohol problems in women and children. New York: Grne & Stratton, 1976: 103-136.
28. Van Thiel DH, Tarter RE, Rosenblum E, Gavaler JS. Ethanol, its metabolism and gonadal effects: does sex make a difference? Adv Alcohol Subst Abuse 1988; 3-4:131-169
29. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS.High blood alcohol levels inwomen: the role of decreased gastric alcohol dehydrogenase and first-pass metabolism. N Engl J Med 1990; 322:95-99
30. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975-2007. Volume I: Secondary school students (NIH Publication No. 08-6418A). Bethesda,MD: National Institute on Drug Abuse, 2008:707.
31. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975-2007. Volume II: College students and adults ages 19-45 (NIH Publication No. 08- 6418B). Bethesda, MD: National Institute on Drug Abuse, 2008:319.
32. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health 2003; 27:209-219
33. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2005. CDC WONDER On-line Database, compiled from Compressed Mortality File 1999-2005 Series 20 No. 2K, 2008. Available at: http://wonder.cdc.gov/cmficd10. html. Accessed March 12, 2009.
34. Tuyns AJ, Ṕequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 1984; 13:53-57
35. Colantoni A, Idilman R, De Maria N, La Paglia N, Belmonte J, Wezeman F, Emanuele N, Van Thiel DH, Kovacs EJ, Emanuele MA. Hepatic apoptosis and proliferation in male and female rats fed alcohol: role of cytokines. Alcohol Clin Exp Res 2003; 27:1184-1189
36. Yoon YH, Yi H, Grant BF, et al. Surveillance Report #57: liver cirrhosis mortality in the United States, 1970-1998. Washington, DC: National Institute on Alcohol Abuse and Alcoholism, 2001.
37. Anderson P. Alcohol and risk of physical harm. In: Holder HD, Edwards G, eds. Alcohol and public policy: evidence and issues. Oxford: Oxford University Press, 1995: 82-113.
38. Becker U, DeisA, Sorensen TI, Gronbaek M, Borch- Johnsen K, Muller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology 1996; 23:1025-1029
39. American Heart Association. Heart Disease and Stroke Statistics-2009 Update. Statistics committee and stroke statistics subcommittee. Circulation. 2008 Dec 15.
40. Foerster M, Marques-Vidal P, Gmel G, Daeppen JB, Cornuz J, Hayoz D, Ṕecoud A, Mooser V, Waeber G, Vollenweider P, Paccaud F, Rodondi N. Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol 2009; 103:361-368
41. Saremi A, Arora R. The cardiovascular implications of alcohol and red wine. Am J Ther. 2008; 15:265-277
42. Ikehara S, Iso H, Toyoshima H, Date C, Yamamoto A, Kikuchi S, Kondo T, Watanabe Y, Koizumi A, Wada Y, Inaba Y, Tamakoshi A. Alcohol consumption and mortality from stroke and coronary heart disease among Japanese men and women. Stroke 2008; 39: 2936-2942
43. American Heart Association. Alcohol, wine and cardiovascular disease. Available at: http://www.americanheart. org/presenter.jhtml?identifier=4422. Accessed March 12, 2009.
44. Plat L, Leproult R, L'Hermite-Baleriaux M, Fery F, Mockel J, Polonsky KS, Van Cauter E. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning. J Clin Endocrinol Metab 1999; 84:3082-3092
45. SpiegelK, Leproult R,Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354:1435-1439
46. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manag 2005; 1:291-299
47. Badrick E,BobakM,BrittonA,Kirschbaum C, Marmot M, Kumari M. The relationship between alcohol consumption and cortisol secretion in an aging cohort. J Clin Endocrinol Metab 2008; 93:750-757
48. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:e21-181.
49. U.S. Department of Health and Human Services, Health Resources and Services Administration. Women's Health USA 2007. Rockville, Maryland: U.S. Department of Health and Human Services, 2007.
50. Wannamethee SG, Field AE, Colditz GA, Rimm EB. Alcohol intake and 8-year weight gain inwomen: a prospective study. Obes Res 2004; 12:1386-1396
51. Schr̈oder H, Morales-Molina JA, Bermejo S, Barral D, Soler Ḿandoli E, Grau M, Guxens M, de Jaime Gil E, Doḿinguez Á lvarez M, Marrugat J. Relationship of abdominal obesity with alcohol consumption at population scale. Eur J Nutr 2007; 46:369-376
52. Hirani V, Zaninotto P, Primatesta P. Generalised and abdominal obesity and risk of diabetes, hypertension and hypertension: diabetes co-morbidity in England. Public Health Nutrition 2008; 11:521-527
53. Howard AA, Arnsten JH, Gourevitch MN. Effect of alcohol consumption on diabetes mellitus: a systematic review. Ann Intern Med 2004; 140:211-219
54. Carlsson S, Hammar N, Valdemar G, Jaakko K. Alcohol consumption and the incidence of type 2 diabetes: A 20 year followup of the Finnish twin cohort study.Diabetes Care 2003; 26:2785-2790
55. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345:790-797
56. Beulens JW, Stolk RP, van der Schouw YT, Grobbee DE, Hendriks HF, Bots ML. Alcohol consumption and risk of type 2 diabetes among olderwomen. Diabetes Care 2005; 28:2933-2938
57. Diabetes Food Pyramid: Alcohol. American Diabetes Association Web site. Available at: http://www. diabetes.org/nutrition-and-recipes/nutrition/alcohol. jsp. Accessed March 12, 2009.
58. Fast Facts on Osteoporosis. National Osteoporosis Foundation Web site. Available at: http://www.nof. org/osteoporosis/diseasefacts.htm#top. Accessed March 12, 2009.
59. Felson DT,KielDP, Anderson JJ, KannelWB. Alcohol consumption and hip fractures: the Framingham study. Am J Epidemiol 1988; 128:1102-1110
60. Kanis JA, Johansson H, Johnell O, Oden A, De Laet C, Eisman JA, Pols H, Tenenhouse A. Alcohol intake as a risk factor for fracture. Osteoporos Int 2005; 16:737-742
61. Williams FM, Cherkas LF, Spector TD, MacGregor AJ. The effect of moderate alcohol consumption on bone mineral density: a study of female twins. Ann Rheum Dis 2005; 64:309-310
62. Diaz NM, O'NeillTW, Silman AJ, and the European Vertebral Osteoporosis Study Group. Influence of alcohol consumption on the risk of vertebral deformity. Osteoporosis International 1997; 7:65-71.
63. Prevention. National Osteoporosis Foundation Web site. Available at: http://www.nof.org/preven-tion/ risk.htm#alcoholabuse. Accessed March 12, 2009.
64. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds). SEER cancer statistics review, 1975-2006: National Cancer Institute. Bethesda, MD. Available at: http:// seer.cancer.gov/csr/ 1975 2006/. Accessed March 12, 2009.
65. Bandera EV, Freudenheim JL, Vena JE. Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev. 2001; 10:813-821
66. Pollack ES, Nomura AM, Heilbrun LK, Stemmermann GN, Green SB. Prospective study of alcohol consumption and cancer. N Engl J Med 1984; 310:617-621
67. Djousśe L, Dorgan JF, Zhang Y, Schatzkin A, Hood M, D'Agostino RB, Copenhafer DL, Kreger BE, Ellison RC. Alcohol consumption and risk of lung cancer: The Framingham Study. J Natl Cancer Inst. 2002; 94:1877-1882 (Pubitemid 36104632)
68. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2005. CDC WONDER On-line Database, compiled from Compressed Mortality File 1999-2005 Series 20 No. 2K, 2008. Available at: http://wonder.cdc.gov/cmficd10. html. Accessed March 12, 2009.
69. Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE,Kawachi I,Hunter DJ, Hankinson SE, Hennekens CH, Rosner B. Alcohol consumption and mortality among women. N Engl JMed 1995; 332:1245-1250
70. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Miller AB, Potter JD, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Hunter DJ. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 2001; 185:769-776
71. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, StasonW, Hennekens CH. Relative and absolute excess risks of coronary heart disease amongwomenwho smoke cigarettes.NEngl JMed 1987; 317:1303-1309
72. Gapstur SM, Potter JD, Sellers TA, Folsom AR. Increased risk of breast cancer with alcohol consumption in postmenopausal women.AmJ Epidemiol 1992; 136:1221-1231
73. Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Doll R. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997; 337:1705-1714
74. Swanson CA, Coates RJ, Malone KE, Gammon MD, Schoenberg JB, Brogan DJ, McAdams M, Potischman N, Hoover RN, Brinton LA. Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology 1997; 8:231-237 (Pubitemid 27183685)
75. Li Y, Baer D, Friedman GD Md, Udaltsova N, Shim V, Klatsky AL. Wine, liquor, beer and risk of breast cancer in a large population. Eur J Cancer 2009; 45: 843-850
76. European Cancer Conference. Alcohol amount, not type-wine, beer, liquor-triggers breast cancer. ScienceDaily. Available from: http://www.sciencedaily.com/ releases/2007/09/070927083251.htm. AccessedMarch 12, 2009.
77. Allen NE, Beral V, Casabonne D, Kan SW, Reeves GK, Brown A, Green J. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst 2009; 101: 296-305.
78. Longnecker MP, Newcomb PA, Mittendorf R, Greenberg ER,ClappRW,BogdanGF, Baron J,MacMahon B, Willett WC. Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst 1995; 87:923-929
79. Swanson CA, Coates RJ, Malone KE, Gammon MD, Schoenberg JB, Brogan DJ. Alcohol consumption and breast cancer risk among women under age 45 years. Epidemiology 1997; 8:231-237
80. Hill HA, Austin H. Nutrition and endometrial cancer. Cancer Causes Control 1996; 7:19-32.
81. Parazzini F, La Vecchia C, D'Avanzo B, Moroni S, Chatenoud L, Ricci E. Alcohol and endometrial cancer risk: findings from an Italian case-control study. Nutr Cancer 1995; 23:55-62.
82. Purohit V.Moderate alcohol consumption and estrogen levels in postmenopausal women: a review. Alcohol Clin Exp Res 1998; 22:994-997
83. Castellsagúe X, Muńoz N, De Stefani E, Victora CG, Castelletto R, Roĺon PA, Quintana MJ. Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women. Int J Cancer 1999; 82:657-664
84. Talamini G, Bassi C, Falconi M, Sartori N, Salvia R, Rigo L, Castagnini A, Di Francesco V, Frulloni L, Bovo P, Vaona B, Angelini G, Vantini I, Cavallini G, Pederzoli P. Alcohol and smoking as risk factors in chronic pancreatitis and pancreatic cancer. Dig Dis Sci 1999; 44:1303-1311 (Pubitemid 29404289)
85. Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA 1984; 252:1905.
86. Seizes ML. The Michigan Alcoholism Screening Test: A quest for a new diagnostic instrument. Am J Psychiatry 1971; 127:89.
87. Hurt RD, Morse RM, Sorenson WM. Diagnosis of alcoholism with a self-administered alcoholism screening test: Results with 1,002 consecutive patients receiving general examinations. Mayo Clin Proc 1980; 55:365.
88. Zilberman ML, Tavares H, Blume SB, el-Guebaly N. Towards best practices in the treatment of women with addictive disorders. Addict Disord Treat 2002; 1:39-46.
89. Beckman LJ. Women alcoholics: a review of social and psychological studies. J Stud Alcohol 1975; 36: 794.
90. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004; 43:1731-7. Available at: http://content.onlinejacc.org/cgi/reprint/43/10/ 1731.pdf. Accessed March 13, 2009.
91. U.S. Department of Health and Human Services. Women and Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2001. Available from: http://www.cdc.gov/ tobacco/data statistics/sgr/sgr 2001/index.htm. Accessed March 13, 2009.
92. Novotny TE, Giovino GA. Tobacco Use. In: Brownson RC, Remington PW, Davis JR (eds). Chronic disease epidemiology and control. American Public Health Association 1993; Washington, DC:117-148
93. U.S. Department of Health and Human Services. Women and smoking: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2001. Available from: http://www.cdc.gov/tobacco/data statistics/sgr/sgr 2001/ index.htm. Accessed March 13, 2009.
94. Centers for Disease Control and Prevention. Perspectives in disease prevention and health promotion, smoking-attributable mortality and years of potential life lost-United States, 1984. Morbidity andMortalityWeekly Report [serial online] 1997; 46:444-51. Available at: http:// www.cdc.gov/mmwr/preview/ mmwrhtml/00047690.htm. Accessed March 13, 2009.
95. Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics, 2002. Cancer J Clin 1999; 49:33-64, 1.
96. Centers for Disease Control and Prevention. Surgeon General's report: the health consequences of smoking. 2004. Available at: http://www.cdc.gov/tobacco/ data statistics/sgr/sgr 2004/index.htm#lights. Accessed March 13, 2009.
97. Centers for Disease Control and Prevention. Fact sheet: women and tobacco. 2006. Available at: http://www.cdc.gov/tobacco/data statistics/Factsheets/ women tobacco.htm. Accessed March 13, 2009.
98. Radzikowska E, Glaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival: population-based study of 20,561 cases. Ann Oncol 2002; 13:1087-1093
99. Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Davis AL, Luketich JD, Siegfried JM. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst 2000; 92:24-33. Available at: http://jnci.oxfordjournals.org/cgi/content/ abstract/92/1/24. Accessed March 12, 2009.
100. World Health Organization. Fact sheet: the top ten causes of death. November 2008. Fact Sheet No 310. Available at: http://www.who.int/mediacentre/ factsheets/fs310 2008.pdf. Accessed March 12, 2009.
101. Centers for Disease Control and Prevention. National vital statistics reports. April 2008. Deaths: Final Data for 2005. Vol 56, No 10. Available online: http: //www.cdc.gov/ nchs/data/ nvsr/nvsr56/nvsr56 10.pdf. Accessed March 12, 2009.
102. American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861-865
103. Fletcher C, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema: an eight-year study of early chronic obstructive lung disease in working men in London. Oxford University Press, New York, 1976.
104. Centers for Disease Control. Mortality patterns- United States, 1993. Morbid Mortal Weekly Rep 1996; 45:161-164
105. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease: the Lung Health Study. Am J Respir Crit Care Med 2000; 161:381-90. Available at: http://ajrccm.atsjournals.org/cgi/reprint/161/2/381. Accessed March 12, 2009.
106. Hennekens CH. Coronary disease: risk intervention. In: Julian DG, Wenger NK eds. Women and heart disease (1st ed.). London: Martin Dunitz, 1997:39-48.
107. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res 2002; 53:538-49. Available at: http://cardiovascres. oxfordjournals.org/cgi/reprint/ 53/3/538. Accessed March 12, 2009.
108. Jonas MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals: American Heart Association. Circulation 1992; 86:1664-1669
109. Black HR. Smoking and cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: pathophysiology, diagnosis and management (2nd ed.). New York: Raven Press Ltd., 1995:2621-2647
110. Price JF,Mowbray PI, LeeAJ, Rumley A, Lowe GD, Fowkes FG. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery study. Eur Heart J 1999; 20:344-353
111. Negri E, Franzosi MG, La Vecchia C, Santoro L, Nobili A, Tognoni G. Tar yield of cigarettes and risk of acute myocardial infarction: GISSI-EFRIM Investigators. BMJ 1993; 306:1567-1570
112. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994; 84:399-404.
113. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N EngI J Med 1990; 322:213-217 (Pubitemid 20034507)
114. Wang XL, Tam C, McCredie RM, Wilcken DE. Determinants of severity of coronary artery disease in Australian men and women. Circulation 1994; 89:1974-81. Available online: http://circ.ahajournals.org/ cgi/reprint/89/5/ 1974. Accessed February 26 2009.
115. American Heart Association. Gender and age differences found in clotting mechanism of sudden cardiac death. Available online: http://www.eurekalert. org/pub releases/1998-04/AHA-GAAD-270498.php. Accessed 9 March 2009.
116. Arbustini E, Dal Bello B, Morbini P, Burke AP, Bocciarelli M, Specchia G, Virmani R. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82:269-72. Available online: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid= 1729173&blobtype=pdf. Accessed March 12, 2009.
117. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation 1998; 97:2110-6. Available at: http://circ.ahajournals.org/ cgi/reprint/97/21/2110. Accessed March 12, 2009.
118. American Cancer Society. Global cancer facts & figures 2007. Available at: http://www.cancer.org/ downloads/STT/Global Facts and Figures 2007 rev2.pdf. Accessed March 12, 2009.
119. IARC Monographs on the evaluation of carcinogenic risks to humans. Tobacco smoke and involuntary smoking. Vol.83. Lyon: IARC; 2004.
120. Nagata C, Mizoue T, Tanaka K, Tsuji I, Wakai K, Inoue M, Tsugane S. Tobacco smoking and breast cancer risk: an evaluation based on a systematic review of epidemiological evidence among the Japanese population. Jpn J Clin Oncol 2006; 36: 387-94. Available online: http://jjco.oxfordjournals.org/cgi/ reprint/36/6/387. Accessed March 12, 2009. (Pubitemid 44043929)
121. Morabia A, Ambrosone CB, Baron JA, Phillips DH, Russo IH. What do we currently know about the epidemiological and biological plausibility of the association of smoking and breast cancer? JWomens Cancer 2001; 3:5-8.
122. Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 2002; 39:119-126
123. Ha M, Mabuchi K, Sigurdson AJ, Freedman DM, LinetMS, Doody MM, Hauptmann M. Smoking cigarettes before first childbirth and risk of breast cancer. Am J Epidemiol 2007; 166:55-61.
124. GeneCards. N-acetyltransferase 2. Last updated Jan 2009. Available online: http://www.genecards.org/cgibin/ carddisp.pl?gene=NAT2. Accessed March 12, 2009.
125. Ambrosone CB, Kropp S,Yang J,Yao S, Shields PG, Chang-Claude J. Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: Pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 2008; 17:15-26.
126. Phillips and Garte. Smoking and breast cancer: is there really a link? Cancer Epidemiol Biomarkers Prev 2008; 17:1-2. Available online: http://cebp.aacrjournals. org/cgi/reprint/17/1/1. Accessed March 12, 2009.
127. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjośe S, Mũnoz N; IARC Multi-centre Cervical Cancer Study Group. Smoking and cervical cancer: pooled analysis of the IARC multicentric case-control study. Cancer Causes Control 2003; 14:805-814
128. Vineis P, Alavanja M, Buffler P, Fontham E, Franceschi S, Gao YT, Gupta PC, Hackshaw A, Matos E, Samet J, Sitas F, Smith J, Stayner L, Straif K, Thun MJ, Wichmann HE, Wu AH, Zaridze D, Peto R, Doll R. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96:99-106. Available at: http://jnci.oxfordjournals. org/cgi/reprint/96/2/99. Accessed March 12, 2009.
129. Kjellberg L, Hallmans G, Ahren AM, Johansson R, Bergman F, Wadell G, Angstrom T, Dilliner J. Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection. Br J Cancer 2000; 82:1332-1338
130. Green A, Purdie D, Bain C, Siskind V, Webb PM. Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control 2001; 12:713-719
131. Zhang Y, Coogan PF, Palmer JR, Strom BL, Rosenberg L. Cigarette smoking and increased risk of mucinous epithelial ovarian cancer. Am J Epidemiol 2004; 159:133-9. Available at: http://aje.oxford-journals. org/cgi/reprint/159/2/133. Accessed March 12, 2009.
132. Lesko SM, Rosenberg L, Kaufman DW, Helmrich SP, Miller DR, Strom B, et al. Cigarette smoking and the risk of endometrial cancer. N Engl J Med 1985; 313: 593-596
133. Brinton LA, Barren RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD. Cigarette smoking and the risk of endometrial cancer. Am J Epidemiol 1993; 137:281-291 (Pubitemid 23090462)
134. Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer 2005; 114:996-1001. Available at: http://www3.interscience.wiley.com/ cgi-bin/fulltext/109865074/PDFSTART. Accessed March 12, 2009. (Pubitemid 40504484)
135. Weiderpass E, Baron JA. Cigarette smoking, alcohol consumption, and endometrial cancer risk: a populationbased study in Sweden. Cancer Causes Control 2001; 12:239-247 (Pubitemid 32515371)
136. Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, Zhu H, Wang B. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008; 121:501-8. Available at: http://download.journals.elsevierhealth. com/pdfs/journals/0002 - 9343/PIIS000293430800 - 1940.pdf. Accessed March 12, 2009. (Pubitemid 351694344)
137. Muscat JE, Stellman SD, Hoffmann D, Wynder EL. Smoking and pancreatic cancer in men and women. Cancer Epidemiol Biomarkers Prev 1997; 6:15-9. Available at: http://cebp.aacrjournals.org/cgi/reprint/6/1/15.pdf. Accessed March 12, 2009. (Pubitemid 27030422)
138. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001; 93:538-45. Available at: http://jnci. oxfordjournals.org/cgi/reprint/93/7/538. Accessed March 12, 2009. (Pubitemid 32318433)
139. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7:497-506. (Pubitemid 26306782)
140. Freedman ND, Abnet CC, Leitzmann MF, Hollenbeck AR, Schatzkin A. Prospective investigation of the cigarette smoking-head and neck cancer association by sex. Cancer 2007; 110:1593-1601 (Pubitemid 47463075)
141. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003; 349:2241-2252. Available at: http: / /www.usagiedu.com / articles /esoca03/ esoca03.pdf. Accessed March 12, 2009. (Pubitemid 37485141)
142. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83:18-29. [Erratum: Int J Cancer 1999; 83:870-3.] (Pubitemid 29409471)
143. Wu AH, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinoma of the stomach and esophagus (United States). Cancer Causes Control 2001; 12:721-732 (Pubitemid 32807718)
144. De Stefani E, Barrios E, Fierro L. Black (air-cured) and blond (flue-cured) tobacco and cancer risk. III. Oesophageal cancer. Eur J Cancer 1993; 29A:763-766 (Pubitemid 23077062)
145. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking inwomen.AmJObstetGynecol 1990; 162:502-514 (Pubitemid 20068531)
146. Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod 1998; 13:1532-1539 (Pubitemid 28310489)
147. Hu FB, Grodstein F, Hennekens CH, Colditz GA, Johnson M, Manson JE, Rosner B, Stampfer MJ. Age at naturalmenopause and risk of cardiovascular disease. Arch Intern Med 1999; 159:1061-1066 (Pubitemid 29230857)
148. Hollenbach KA, Barrett-Connor E, Edelstein SL, Holbrook T. Cigarette smoking and bone mineral density in older men and women. American Journal of Public Health 1993; 83:1265-1270. (Pubitemid 23262031)
149. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of amajor effect.BMJ 1997; 315:841-846
150. Department of Health and Human Services; Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings [monograph on the Internet]. Available at: http://www.oas.samhsa.gov/NSDUH/2k7NSDUH/2k7- results.cfm. Accessed March 12, 2009.
151. Manchikanti L. Prescription drug abuse: what is being done to address the new drug epidemic? Testimony before the subcommittee on criminal justice, drug policy and human resources. Pain Physician 2006; 9:287-321. (Pubitemid 44717789)
152. Educating Voices. Oxycontin facts. Available from: http://www. educatingvoices.org/OXYCONTIN.asp.
153. Educating Voices Heroin facts. Available from: http://www. educatingvoices.org/HEROIN.asp.
154. Calefati J. Heroin hits the suburbs hard amid wave of drug abuse by teens and 20-somethings.Available at: http:// www.usnews.com/articles/news/national/ 2008/12/05/ heroin-hits-the-suburbs-hard-amid-wave-of-drug-abuseby- teens-and-20-somethings.html. Accessed March 12, 2009.
155. Simoni-Wastila L, Yang HK. Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother 2006; 4:380-394 (Pubitemid 46222212)
156. Anglin MD, Hser YI, McGlothlin WH. Sex differences in addict careers. 2. Becoming addicted. Am. J. Drug Alcohol Abuse 1987; 13:59-71. (Pubitemid 17085755)
157. Arfken CL, Klein C, di Menza S, Schuster CR. Gender differences in problem severity at assessment and treatment retention. J Subst Abuse Treat 2001; 20:53-57 (Pubitemid 32178181)
158. Olsen GD, Wilson JE, Robertson GE. Respiratory and ventilatory effects of methadone in healthy women. Clin Pharmacol Ther 1981; 29:373-380 (Pubitemid 11134115)
159. Nettleton RT, Ransom TA, Abraham SL, Nelson CS, Olsen GD. Methadone-Induced Respiratory Depression in the NeonatalGuinea Pig. Pediatr Pulmonol 2007; 42:1134-1143
160. Neal RC, Olsen GD. The effects of methadone on respiration and ventilation in Pygmy goats. J Pharmacol Exp Ther1980; 215:45-52.
161. Fanoe S, Jensen GB, Sjøgren P, Korsgaard MP, Grunnet M. Oxycodone is associated with dose-dependent QTc prolongation in patients and low-affinity inhibiting of hERG activity in vitro. Br J Clin Pharmacol 2009; 67: 172-179
162. T́oth AR, Varga T. Myocardium and striated muscle damage caused by licit or illicit drugs. Journal of Legal Medicine. In press.
163. Hosseini SY, Safarinejad MR, Amini E, Hooshyar H. Opium consumption and risk of bladder cancer: A casecontrol analysis. Urol Oncol 2008 Dec 24. [Epub ahead of print].
164. Aliasgari M, Kaviani A, Gachkar L, Hosseini- Nassab S. Is bladder cancer more common among opium addicts? Urol J 2004; 1:253-254
165. Nasrollahzadeh D, Kamangar F, Aghcheli K, Sotoudeh M, Islami F, Abnet CC, Shakeri R, Pourshams A, Marjani HA, Nouraie M, Khatibian M, Semnani S, Ye W, Boffetta P, Dawsey SM, Malekzadeh R. Opium, tobacco, and alcohol use in relation to esophageal squamous cell carcinoma in a high-risk area of Iran. Br J Cancer 2008; 98:1857-1863
166. Mousavi MR, Damghani MA, Haghdoust AA, Khamesipour A. Opium and risk of laryngeal cancer. Laryngoscope 2003; 113:1939-1943
167. Ribeiro-Pinto LF, Swann PF. Opium and esophageal cancer: Effect of morphine and opium on the metabolism of N-nitrosodimethylamine and N-nitrosodiethylamine in the rat. Carcinogenesis 1997; 18:365-369
168. Sacerdote P, Limiroli E, Gaspani L. Experimental evidence for immunomodulatory effect of opioids. In: Machelska H, Stein C, eds. Immune Mechanisms of pain and analgesia, advances in experimental medicine and biology. New York: Kluwer Academic Press, 2001; 521:106-112
169. Sacerdote P. Opioids and the immune system. Palliat Med 2006; 20(Suppl 1):S9-15.
170. Vallejo R, de Leon-Casasola O, Benyamin R. Opioid therapy and immunosuppression: A review. Am J Ther 2004; 11:354-365
171. Risdahl JM, Khanna KV, Peterson PK, Molitor TW. Opiates and infection. J Neuroimmunol 1998; 83:4-18.
172. Wang J, Barke RA, Charboneau R, Roy S. Morphine impairs host innate immune response and increases susceptibility to Streptococcus pneumoniae lung infection. J Immunol 2005; 174:426-434
173. Guerra D, Sole A, Cami J, Tobena A. Neuropsychological performance in opiate addicts after rapid detoxification. Drug Alcohol Depend 1987; 20: 261-270
174. Kamboj SK, Tookman A, Jones L, Curran HV. The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 2005; 117:388-395
175. Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend 2002; 67:41-51.
176. Ornstein TJ, Iddon JL, Baldacchino AM, Sahakian BJ, London M, Everitt BJ, Robbins TW. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 2000; 23:113-126.
177. Sjogren P, Christrup LL, Petersen MA, Hojsted J. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre. Eur J Pain 2005; 9:453-462
178. Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker I. Neuropsychological functioning in opiatedependent subjects receiving and following methadone maintenance treatment. Drug Alcohol Depend 2006; 84:240-247
179. Lee TM, Pau CW. Impulse control differences between abstinent heroin users and matched controls. Brain Inj 2002; 16:885-889
180. Davydov DM, Polunina AG. Heroin abusers' performance on the Tower of London Test relates to the baseline EEG alpha2 mean frequency shifts. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:1143-1152
181. Wang JH, Liu XF, ChenYM, SunHY, FuY, Ma MX, He J,Wang HY,Wilson FA, Carlson S, Ma YY. Heroin impairs map-picture-following and memory tasks dependent on gender and orientation of the tasks. Behav Neurosci 2007; 121:653-664
182. Liu N, Li B, Wilson FA, Ma Y, Hu X.Gender effect on the right-left discrimination task in a sample of heroin-dependent patients. Psychopharmacology (Berl) 2005; 181:735-740
183. Marzuk PM, Tardiff K, Leon AC, Portera L, Weiner C. Fatal injuries after cocaine use as a leading cause of death among young adults in New York City. N Engl J Med 1995; 332:1753-57. Available at: http://content. nejm.org/cgi/ content/full/332/26/1753. Accessed March 12, 2009.
184. Griffin ML, Weiss RD, Lange U. A comparison of male and female cocaine abuse. Arch Gen Psychiatry 1989; 46:122-126
185. White KA, Brady KT, Sonne S. Gender differences in patterns of cocaine use. Am J Addict 1996; 5: 259-261
186. Haas AL, Peters RH. Development of substance abuse problems among drug-involved offenders. Evidence for the telescoping effect. J Subst Abuse 2000; 12: 241-253
187. Kosten TA, Gawin FH, Kosten TR, Rounsaville BJ. Gender differences in cocaine use and treatment response. J Subst Abuse Treat 1993; 10:63-66
188. Mendelson JH,Weiss R, Griffin M, Mirin SM, Teoh SK, Mello NK, Lex BW. Some special considerations for treatment of drug abuse and dependence in women. NIDA Res Monogr 1991; 106:313-327
189. Karch SB. Cocaine cardiovascular toxicity. South Med J 2005; 98:794.
190. Evans SM, Haney M, Fischman MW, Foltin RW. Limited sex differences in response to "Binge" smoked cocaine use in humans. Neuropsychopharmacology 1999; 21:445-454
191. Dudish SA, Hatsukami DK. Gender differences in crack users who are research volunteers. Drug Alcohol Depend 1996; 42:55-63.
192. Ou DW, Shen ML, and Luo YD. Effects of cocaine on the immune system of Balb/C mice. Clin Immunol Immunopathol 1989; 52:305-312
193. Baldwin, GC, Roth, MD, Tashkin, DP. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 1998; 83: 133-138
194. Cook JA, Burke-Miller JK, Cohen MH, Cook RL, Vlahov D, Wilson TE, Golub ET, Schwartz RM, Howard AA, Ponath C, PlankeyMW, Levine AM, Grey DD. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 2008; 22: 1355-1363
195. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst 1998; 90:1198-205. Available online: http://jnci.oxfordjournals. org/cgi/reprint/90/16/1198. Accessed March 12, 2009.
196. Slaughter DP, Southwick HW, Smejkal W. 'Field cancerization' in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 1953; 6:963-968
197. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63:1727-1730
198. Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmaco. 1999; 7:274-283
199. Justice AJ, de Wit H. Acute effects of damphetamine during the follicular and luteal phases of themenstrual cycle in women. Psychopharmacology (Berl) 1999; 145:67-75.
200. Wisniewski AB, Brown TT, Cofranceso JM, Golub ET, Ricketts EP, Wand G, Dobs AS. Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology 2006; 31:250-255
201. Tjaden P, Thoennes N. Extent, nature, and consequences of intimate partner violence: findings from the National Violence Against Women Survey. Washington, DC: Department of Justice; 2000. Publication No. NCJ 181867. Available at: www.ojp.usdoj.gov/nij/pubssum/ 181867.htm. Accessed March 12, 2009.
202. Bureau of Justice StatisticsWeb site. Intimate homicide victims by gender. Available at: http://www.ojp. usdoj.gov/bjs/homicide/intimates.htm. Accessed March 12, 2009.
203. Caetano R, Schafer J, Cunradi CB. Alcohol-related intimate partner violence among White, Black, and Hispanic couples in the United States. Alcohol Res Health 2001; 25:58-65.
204. Kantor GK, Straus MA. Substance abuse as a precipitant of wife abuse victimization. Am J Drug Alcohol Abuse 1989; 15:173-189
205. Leonard KE, Senchak M. Prospective prediction of husband marital aggression within newlywed couples. J Abnorm Psychol 1996; 105:369-380
206. Miller BA, Downs WR, Gondoli DM. Spousal violence among alcoholic women as compared to a random household sample ofwomen. J StudAlcohol 1989; 50:533-540
207. O'Farrell TJ, Van Hutton V, Murphy CM. Domestic violence before and after alcoholism treatment :A two-year longitudinal study. J Stud Alcohol 1999; 60: 317-321
208. Kyriacou DN, Anglin D, Taliaferro E, Stone S, Tubb T, Linden JA, Muelleman R, Barton E, Kraus JF. Risk factors for injury to women from domestic violence. N Engl J Med 1999; 341:1892-1898
209. Toman, RM. Rosen D. Domestic violence in the lives of women receiving welfare mental health, substance dependence, and economic well-being. Violence Against Women 2001; 7:141-158
210. Slade M, Daniel LJ, Heisler CJ. Application of forensic toxicology to the problem of domestic violence. JFS 1991; 36:708-713
211. UNAIDS (2006). Annex 2: HIV and AIDS estimates and data, 2005 and 2003. Available at: http://data.unaids. org/pub/GlobalReport/2006/2006 GR ANN2 en.pdf. Accessed March 12, 2009.
212. AIDSinfo (2008). HIV infection in women: overview 2006. AIDSinfo Web site. Available from: http://www.aidsinfo.nih.gov/. Accessed March 12, 2009.
213. UNAIDS Epidemic Update, Dec. 2007; UNAIDS, Report on the global AIDS epidemic, 2008; Kaiser Family Foundation; U.S. Centers for Disease Control and Prevention, 2008.
214. Curran JW, Jaffe HW, Hardy AM, Morgan WM, Selik RM, Dondero TJ. Epidemiology of HIV infection andAIDS in the United States. Science 1988; 239:610-616
215. Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health 1987; 77:169-172
216. Marmor M, Des Jarlais DC, Cohen H, Friedman SR, Beatrice ST, Dubin N, el-Sadr W, Mildvan D, Yancovitz S, Mathur U, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug users in New York City. AIDS 1987; 1:39-44.
217. Fullilove MT, Golden E, Fullilove RE 3rd, Lennon R, Porterfield D, Schwarcz S, Bolan G. Crack cocaine use and high-risk behaviors among sexually active black adolescents. Adolesc Health 1993; 4:295-300.
218. Booth RE, Watters JK,Chitwood DD. HIV riskrelated sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health 1993; 83:1144-1148
219. Zenilman JM, Hook EW, 3rd, Shepherd M, Smith P, Rompalo AM, Celentano DD. Alcohol and other substance use in STD clinic patients: relationships with STDs and prevalent HIV infection. Sex Transm Dis 1994; 21: 220-225
220. Fisher JC, Cook PA, Sam NE, Kapiga SH. Patterns of alcohol use, problem drinking, and HIV infection among high-risk African women. Sex Transm Dis 2008; 35: 537-544
221. Hutton HE, McCaul ME, Santora PB, Erbelding EJ.The relationship between recent alcohol use and sexual behaviors: gender differences among sexually transmitted disease clinic patients. Alcohol Clin Exp Res 2008; 32:2008-2015